Cargando…
Monoclonal Antibodies in Multiple Sclerosis: Present and Future
The global incidence of multiple sclerosis (MS) appears to be increasing. Although it may not be associated with a high mortality rate, this disease has a high morbidity rate which affects the quality of life of patients and reduces their ability to do their activities of daily living. Thankfully, t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466331/ https://www.ncbi.nlm.nih.gov/pubmed/30875812 http://dx.doi.org/10.3390/biomedicines7010020 |